Illumina Inc.

Company Website

9885 Towne Centre Dr.
San Diego, CA 92121

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Illumina Inc.

Market Cap as of 6/12/2015

$31,386,421,248

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

$9,299,908,203

Market Cap as of 06/26/2012

$4,825,582,520

Market Cap as of 01/04/2012

$3,907,999,000

Market Cap as of 06/20/2011

$8,914,757,000

Market Cap as of 01/06/2011

$8,377,946,000

Exchange and Ticker Symbol

Nasdaq: ILMN

Fields of Research

Develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation and biological function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa

Major Products

HiSeq 2000, HiSeq 1000, MiSeq sequencing systems;
HiScanSQ;
BeadXpress Readers;
standard sequencing kits;
InfiniumHD Whole-Genome BeadChips;
HumanOmni5-Quad, HumanOmni2.5, and HumanOmni1S BeadChips;
BovineHD and MaizeSNP50 BeadChips

View all the companies in San Diego Publicly Traded Companies

Illumina Inc.

Market Cap as of 6/12/2015

$31,386,421,248

Exchange

NASDAQ GS

Ticker

ILMN

Executives

Jay Flatley (profile)

  • Chief Executive Officer
  • President